Author:
AZUMA Hiroshi,TAKASHIMA Yoshimi,ISHIKAWA Masayuki,SASA Masashi,FUJIWARA Motohatsu
Reference15 articles.
1. Studies on antiatherosclerotic agents IX. Synthesis of 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1 (2H)-phthalazinone (EG626);Ishikawa;Chem. Pharm. Bull.,1980
2. Selective inhibition of separated forms of platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors;Asano;Mol. Pharmacol.,1977
3. Changes in cyclic-AMP and cyclic-GMP phosphodiesterase in the progression and regression of experimental atherosclerosis;Numano;Ann. N. Y. Acad. Sci.,1976
4. Phosphodiesterase inhibitors: Their comparative effectiveness in vitro in various organs;Numano;Japan. J. Pharmacol.,1977
5. Cyclic-AMP phosphodiesterase (cAMP PDE) inhibitors in the treatment of senile metal deterioration, cerebellar ataxia and thrombotic and atherosclerotic disorders;Shimamoto,1979